Antimicrobial Prophylaxis for Children with Vesicoureteral Reflux

Members of the writing group (Alejandro Hoberman, M.D., Children’s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh; Saul P. Greenfield, M.D., Women and Children’s Hospital of Buffalo, Buffalo, NY; Tej K. Mattoo, M.D., Wayne State University School of Medicine, Detroit; Ron Keren, M.D., M.P.H., Children’s Hospital of Philadelphia, Philadelphia; Ranjiv Mathews, M.D., Johns Hopkins School of Medicine, Baltimore; Hans G. Pohl, M.D., Children’s National Medical Center, Washington, DC; Bradley P. Kropp, M.D., University of Oklahoma Health Sciences Center, Oklahoma City; Steven J. Skoog, M.D., Oregon Health and Science University, Portland; Caleb P. Nelson, M.D., M.P.H., Boston Children’s Hospital, Boston; Marva MoxeyMims, M.D., National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; Russell W. Chesney, M.D., Le Bonheur Children’s Hospital, Memphis, TN; and Myra A. Carpenter, Ph.D., University of North Carolina at Chapel Hill, Chapel Hill) assume responsibility for the content of this article. Address reprint requests to Dr. Hoberman at Children’s Hospital of Pittsburgh, General Academic Pediatrics, 3414 Fifth Ave., CHOB 3rd Fl., Rm. 321, Pittsburgh, PA 15213, or at [email protected].